Drug shortages & patent expiration: Authorized generics as more than a lifecycle strategy

We spoke with Dr. Cary Yonce, Vice President of General Therapeutics and Life Cycle Management at Sanofi, about the patient demand for generic Arava and the company's response to that demand 10 years after patent expiry.

By Nicole Gray • Oct. 27, 2015

Chinese firm plans large-scale production of Ebola vaccine

Tianjin CanSino Biotechnology, which is privately held, is investing $315 million in an Ebola vaccine-maufacturing facility. 

By Nicole Gray • Oct. 15, 2015

Glaxo shutting down French research lab, laying off 70 employees

Work that was being done at the plants will shift to global hubs.

By Nicole Gray • Sept. 28, 2015

Study: Cancer drugs in US cost up to 6,000% of production cost

Patients in the U.S. pay more than twice as much for tyrosine kinase inhibitors (TKIs), used to treat cancer, than their European counterparts.

By Nicole Gray • Sept. 23, 2015

10th Indian pharma plant this year makes FDA's do-not-import list

Once again, the problem at hand is production quality. 

By Nicole Gray • Sept. 15, 2015

Georgia opens $14M bioscience training center next to Baxalta plant

The new Bioscience Training Center is across the street from Baxalta's $1 billion biomanufacturing plant in Covington, GA. 

By Nicole Gray • Sept. 11, 2015

Russia's Putin reiterates commitment to 90% domestic drug-making by 2020

Pharma 2020 was launched in 2011 by Vladimir Putin in order to intensify domestic investment in the national pharmaceutical industry. 

By Nicole Gray • Sept. 10, 2015

Moody's upgrades financial outlook for biopharma industry

The ratings firm shifted the sector from "stable" to "positive" based on success of new products.

By Nicole Gray • Sept. 4, 2015

How 2014 became a banner year for biotech job growth in MA

The state has been a biotech petri dish for a while now—and new data shows just how much of a hub it's really become.

By Nicole Gray • Sept. 2, 2015

Biosimilars Council chief answers 6 key questions about biosims in the US

Dr. Bert Liang spoke with us to answer questions about the rapid pace of developments as biosimilars become a permanent part of healthcare in America.  

By Nicole Gray • Sept. 2, 2015

How do you solve a problem like drug shortages?

In 2011, there were 251 new drug shortages. That number has dwindled significantly—but there's still work to be done.

By Nicole Gray • Aug. 31, 2015

Tables turned: Mylan cited by FDA for quality violations at Indian plants

The regulatory warning comes with no small amount of irony.

By Nicole Gray • Aug. 19, 2015

UPDATE: Glaxo to reopen NC plant this weekend after Legionnaires' scare

The bacteria were found in a cooling tower, and nearly half of the plant's employees have been told to stay away until the situation is cleared up. 

By Sy Mukherjee • Aug. 12, 2015

Where biotech is booming: From Boston, to Raleigh, and beyond

Rents in the Boston biohub are up 7.4%, compared with 2014, to $47.40 per square foot.

By Nicole Gray • Aug. 7, 2015

Bayer, Berkeley-based biotech labor union settle 4-year contract

It includes annual raises of at least 3.2%. 

By Nicole Gray • Aug. 5, 2015

Aprecia's Spritam becomes first FDA-approved 3D printed medication

The drug is meant to treat various types of seizures in children and adults with epilepsy. 

By Nicole Gray • Aug. 4, 2015

Hospira's painkiller recall is ballooning—Is Pfizer getting nervous?

Ketorolac tromethamine is a painkiller used during surgery—and is now on the FDA shortage list as Hospira has to recall even more vials of the drug.

By Nicole Gray • July 29, 2015

Sandoz closing three German and Indian factories

Division head Richard Francis has annouced site closures in Gerlingen and Frankfurt, Germany, as well as Turbhe, India by the end of 2016. 

By Nicole Gray • July 27, 2015

Innovation vs. access: The big drug battle in Trans-Pacific Partnership negotiations

The generics industry worries over the intellectual property provisions of the complex trade agreement.

By Nicole Gray • July 17, 2015

Sun Pharma slashing Ranbaxy's contract manufacturing unit

The division head and other executives have been given severance packages.

By Nicole Gray • July 16, 2015

Sandoz closing plant in India

As part of its efforts to streamline operations, Sandoz is closing an API plant in Mumbai. 

By Nicole Gray • July 16, 2015

J&J could reopen closed factory, revive OTC business

In 2010, quality-control problems led J&J to close a PA-based factory where OTC meds were manufactured. It could reopen soon.

By Nicole Gray • July 15, 2015

White House meeting focuses on reducing use of antibiotics

Hospitals, food producers, and others were encouraged to pledge a reduction in their use of antibiotics to combat resistance.

By Nicole Gray • June 3, 2015

Teva to pay record $1.2B settlement in Provigil case

The pharma firm will pay the FTC for moving to stop generic competitors from entering the market for its sleep disorder drug.

By Randy Lilleston • May 29, 2015

Gilead on R&D hiring spree

Now that its new lab is open in Edmonton, Canada, the company wants to hire up to 170 scientists. 

By Nicole Gray • May 29, 2015